Next Article in Journal
Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo Experiments
Next Article in Special Issue
New Strategies to Develop Novel Pain Therapies: Addressing Thermoreceptors from Different Points of View
Previous Article in Journal
Photodynamic Therapy with Hypericin Improved by Targeting HSP90 Associated Proteins
Pharmaceuticals 2011, 4(11), 1503-1517; doi:10.3390/ph4111503

Notes on Article Versions

article html file updated23 January 2013 01:52 CET
article html file updated26 January 2013 06:10 CET
article html file updated29 January 2013 00:31 CET
article html file updated6 February 2013 03:33 CET
article html file updated6 February 2013 23:26 CET
article xml file uploaded17 June 2014 04:42 CEST
article html file updated17 June 2014 04:42 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert